home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Vera Therapeutics, Inc. - Class A Common Stock (NQ:VERA)

43.50 +2.55 (+6.23%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vera Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 04, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 04, 2023

On Wednesday, 35 companies reached new 52-week lows.

Via Benzinga

Nasdaq Rises Over 100 Points; Crude Oil Drops Sharply ↗

January 04, 2023

U.S. stocks extended gains midway through trading, with the Dow Jones gaining around 250 points on Wednesday ahead of the release of minutes from the Fed's meeting.

Via Benzinga

These 2 Nasdaq Biotechs Are Making Big Moves Wednesday ↗

January 04, 2023

The binary nature of biotech investing is making itself obvious from recent study results.

Via The Motley Fool

Vera Therapeutics: Q1 Earnings Insights ↗

May 16, 2022

Vera Therapeutics (NASDAQ:VERA) reported its Q1 earnings results on Monday, May 16, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Vera Stock Crashed 60% On Its 'Positive' Kidney Drug Update — And Chinook Popped ↗

January 04, 2023

The "devil is in the details" when it comes to comparing data across studies.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023 ↗

January 04, 2023

Via Benzinga

US Stocks Open Higher Ahead Of Fed Minutes; Dow Rises 100 Points ↗

January 04, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 04, 2023

Via Benzinga

Why Oblong Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket ↗

January 04, 2023

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 04, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

Vera Therapeutics Shares Plunge After Mixed Data From Rare Kidney Disease Study ↗

January 04, 2023

Via Benzinga

Vera Therapeutics, Phathom Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

January 04, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Tesla, Amazon, Apple, Aurinia Pharma, Vera Therapeutics: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

January 03, 2023

Major Wall Street indices closed in the red on Tuesday, the first trading day of 2023, as concerns over rising rates and inflation still seem to drive investor sentiments.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 03, 2023

Via Benzinga

Vera Therapeutics Announces Positive Topline Results of Phase 2b ORIGIN Clinical Trial of Atacicept for the Treatment of IgA Nephropathy

January 03, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

December 20, 2022

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics to Present at Upcoming Investor Conferences

November 22, 2022

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics to Host Key Opinion Webinar on Targeting the Source of IgA Nephropathy (IgAN) Featuring Jonathan Barratt, Ph.D., FRCP

November 17, 2022

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results

November 09, 2022

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics Presents New Analysis of Phase 2a JANUS Trial of Atacicept in IgA Nephropathy and Positive Final Phase 2 Results of MAU868 in Kidney Transplant Recipients with Reactivated BK Virus Infection at the American Society of Nephrology Kidney

November 05, 2022

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics to Present Final Phase 2 Results of MAU868 in Kidney Transplant Recipients with Reactivated BK Virus Infection and New Analysis of Phase 2a JANUS Trial of Atacicept in IgA Nephropathy at the American Society of Nephrology Kidney Week

October 17, 2022

From Vera Therapeutics

Via GlobeNewswire

Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday ↗

September 06, 2022

Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Vera Therapeutics: Here's What You Need To Know ↗

August 22, 2022

HC Wainwright & Co. has decided to maintain its Buy rating of Vera Therapeutics (NASDAQ:VERA) and raise its price target from $35.00 to $36.00. Shares of Vera Therapeutics are trading down 1.88% over...

Via Benzinga

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara ↗

May 20, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022 ↗

July 12, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022 ↗

May 02, 2022

Upgrades

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 13, 2022

During Monday's trading, 1214 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2022 ↗

April 19, 2022

Upgrades

Via Benzinga

Executives Buy Over $93M Of 3 Stocks ↗

April 05, 2022

Although U.S. stocks dropped on Tuesday, there were a few notable insider trades.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com